Max Robotics — Global Service Robot Directory + US Certification

About

Xiang Da Dong is a leading figure in the advancement of robotic surgical oncology, with a primary focus on complex hepatopancreatobiliary and colorectal procedures. His most impactful contribution is a landmark meta-analysis demonstrating that robotic pancreaticoduodenectomy yields superior histopathological outcomes compared to the traditional open approach, a finding that has garnered 59 citations and is reshaping standards in pancreatic cancer surgery. Dr. Dong has also pioneered the simultaneous robotic resection of colon and liver metastases, a technically demanding procedure that expands treatment options for stage IV colorectal cancer. During the COVID-19 pandemic, he provided critical guidance on adapting robotic colorectal surgery protocols to ensure patient and staff safety. His work extends to surgical education through telementoring and teleproctoring, as well as innovative techniques like robotic retrogastric cystogastrostomy for pancreatic pseudocysts and duodenal resections for GIST tumors. By consistently demonstrating that robotic platforms can improve oncologic precision and patient outcomes, Dr. Dong is at the forefront of defining the next generation of minimally invasive cancer surgery.